137 related articles for article (PubMed ID: 22560713)
21. The economics of temozolomide in brain cancer.
Crott R
Expert Opin Pharmacother; 2007 Aug; 8(12):1923-9. PubMed ID: 17696793
[TBL] [Abstract][Full Text] [Related]
22. Temozolomide for pediatric high-grade gliomas.
Packer RJ
Curr Neurol Neurosci Rep; 2012 Apr; 12(2):111-3. PubMed ID: 22249491
[No Abstract] [Full Text] [Related]
23. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
Schiff D
Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma].
Wang L; Tu Q; Zhou W; Zhou R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1106-10. PubMed ID: 22169729
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma.
Yang TM; Wang HC; Lin YJ; Lin WC; Lu CH; Chang WN; Chang HW; Ho JT
Surg Neurol; 2008 Dec; 70 Suppl 1():S1:60-3. PubMed ID: 19061770
[TBL] [Abstract][Full Text] [Related]
26. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases.
Antonadou D; Paraskevaidis M; Sarris G; Coliarakis N; Economou I; Karageorgis P; Throuvalas N
J Clin Oncol; 2002 Sep; 20(17):3644-50. PubMed ID: 12202665
[TBL] [Abstract][Full Text] [Related]
27. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).
Linz U
Cancer; 2010 Apr; 116(8):1844-6. PubMed ID: 20151424
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.
Mirimanoff RO; Gorlia T; Mason W; Van den Bent MJ; Kortmann RD; Fisher B; Reni M; Brandes AA; Curschmann J; Villa S; Cairncross G; Allgeier A; Lacombe D; Stupp R
J Clin Oncol; 2006 Jun; 24(16):2563-9. PubMed ID: 16735709
[TBL] [Abstract][Full Text] [Related]
29. Sequential proton boost after standard chemoradiation for high-grade glioma.
Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
[TBL] [Abstract][Full Text] [Related]
30. Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy.
Baumert BG; Stupp R; ;
Ann Oncol; 2008 Sep; 19 Suppl 7():vii217-22. PubMed ID: 18790954
[No Abstract] [Full Text] [Related]
31. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.
Combs SE; Bruckner T; Mizoe JE; Kamada T; Tsujii H; Kieser M; Debus J
Radiother Oncol; 2013 Jul; 108(1):132-5. PubMed ID: 23932193
[TBL] [Abstract][Full Text] [Related]
32. Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews.
Coskun M; Straube W; Hurkmans CW; Melidis C; de Haan PF; Villà S; Collette S; Weber DC
Radiat Oncol; 2013 Jan; 8():23. PubMed ID: 23363568
[TBL] [Abstract][Full Text] [Related]
33. Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.
Nayak L; de Groot J; Wefel JS; Cloughesy TF; Lieberman F; Chang SM; Omuro A; Drappatz J; Batchelor TT; DeAngelis LM; Gilbert MR; Aldape KD; Yung AW; Fisher J; Ye X; Chen A; Grossman S; Prados M; Wen PY
J Neurooncol; 2017 Mar; 132(1):181-188. PubMed ID: 28116649
[TBL] [Abstract][Full Text] [Related]
34. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.
Gorlia T; van den Bent MJ; Hegi ME; Mirimanoff RO; Weller M; Cairncross JG; Eisenhauer E; Belanger K; Brandes AA; Allgeier A; Lacombe D; Stupp R
Lancet Oncol; 2008 Jan; 9(1):29-38. PubMed ID: 18082451
[TBL] [Abstract][Full Text] [Related]
35. The evolution of chemoradiation for glioblastoma: a modern success story.
Mirimanoff RO
Curr Oncol Rep; 2006 Jan; 8(1):50-3. PubMed ID: 16464403
[TBL] [Abstract][Full Text] [Related]
36. Current and future developments in the use of temozolomide for the treatment of brain tumours.
Stupp R; Gander M; Leyvraz S; Newlands E
Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
Minniti G; Scaringi C; De Sanctis V; Lanzetta G; Falco T; Di Stefano D; Esposito V; Enrici RM
J Neurooncol; 2013 Jan; 111(2):187-94. PubMed ID: 23129347
[TBL] [Abstract][Full Text] [Related]
38. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations.
Chaskis C; Neyns B; Michotte A; De Ridder M; Everaert H
Surg Neurol; 2009 Oct; 72(4):423-8. PubMed ID: 19150114
[TBL] [Abstract][Full Text] [Related]
39. Should radiotherapy be standard therapy for brain tumors in the elderly? Cons.
Chinot OL
Semin Oncol; 2003 Dec; 30(6 Suppl 19):68-71. PubMed ID: 14765390
[TBL] [Abstract][Full Text] [Related]
40. Spanish co-operative group of Medical Neuro-oncology (GENOM).
Contreras Martínez J; Azcoaga Blasco JM; Delgado Rico R; Wals Zurita A; Villanueva Alvarez A; Rivas Sánchez D; Herruzo Cabrera I
Clin Transl Oncol; 2006 Oct; 8(10):770. PubMed ID: 17074680
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
